Literature DB >> 31444073

Prevalence of atrial fibrillation before cardiac surgery and factors associated with concomitant ablation.

Patrick M McCarthy1, Charles J Davidson2, Jane Kruse3, Daniel J Lerner4, Mary Jo Braid-Forbes5, Michelle M McCrea5, Ahmed M Elmouelhi6, Michael A Ferguson6.   

Abstract

OBJECTIVE: Surgical ablation for atrial fibrillation concomitant with cardiac surgery is now a Class I recommendation for selected patients. Understanding how the revised recommendations will affect appropriate use of surgical ablation is challenging because the reported prevalence of preoperative atrial fibrillation depends on the definition used. The objective was to determine the prevalence of atrial fibrillation in the 3 years before cardiac surgery and the rate of concomitant surgical ablation.
METHODS: Patients with and without a diagnosis of atrial fibrillation in the 3 years before surgical coronary artery bypass, aortic valve replacement, or mitral valve replacement/repair were identified in the 2014 Medicare Standard Analytical File.
RESULTS: Patients had prior atrial fibrillation in 28.4% of 79,134 cardiac surgeries. Prior atrial fibrillation was associated with risk factors for increased cardiac surgical morbidity/mortality, including recent heart failure, renal failure, and lung disease. Black patients were less likely to have prior atrial fibrillation but more likely to have had infrequent care for it. Isolated coronary artery bypass had the lowest prevalence but highest absolute number of prior atrial fibrillation cases. Concomitant surgical ablation was performed in 22.1% of patients with prior atrial fibrillation. Patients with mitral valve surgery were 3-fold more likely to receive surgical ablation. Women were less likely to have prior atrial fibrillation but less likely to have surgical ablation when they did.
CONCLUSIONS: Medicare beneficiaries had a substantially higher prevalence of atrial fibrillation diagnoses in the 3 years before cardiac surgery than previously published rates of preoperative atrial fibrillation. Concomitant surgical ablation was performed in less than one-quarter of patients with atrial fibrillation undergoing cardiac surgery for other indications.
Copyright © 2019 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Medicare; atrial fibrillation; atrial fibrillation surgical ablation; cardiac surgery

Mesh:

Year:  2019        PMID: 31444073     DOI: 10.1016/j.jtcvs.2019.06.062

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  5 in total

1.  Oral anticoagulant treatment after bioprosthetic valvular intervention or valvuloplasty in patients with atrial fibrillation-A SWEDEHEART study.

Authors:  Christina Christersson; Claes Held; Angelo Modica; Johan Westerbergh; Gorav Batra
Journal:  PLoS One       Date:  2022-01-13       Impact factor: 3.240

Review 2.  Surgery and Catheter Ablation for Atrial Fibrillation: History, Current Practice, and Future Directions.

Authors:  Patrick M McCarthy; James L Cox; Olga N Kislitsina; Jane Kruse; Andrei Churyla; S Chris Malaisrie; Christopher K Mehta
Journal:  J Clin Med       Date:  2021-12-31       Impact factor: 4.241

3.  Clinical Insights to Complete and Incomplete Surgical Revascularization in Atrial Fibrillation and Multivessel Coronary Disease.

Authors:  Michal Pasierski; Jakub Staromłyński; Janina Finke; Radoslaw Litwinowicz; Grzegorz Filip; Adam Kowalówka; Wojciech Wańha; Michalina Kołodziejczak; Natalia Piekuś-Słomka; Andrzej Łoś; Sebastian Stefaniak; Wojciech Wojakowski; Marek Jemielity; Jan Rogowski; Marek Deja; Dariusz Jagielak; Krzysztof Bartus; Silvia Mariani; Tong Li; Matteo Matteucci; Daniele Ronco; Federica Jiritano; Dario Fina; Gennaro Martucci; Paolo Meani; Giuseppe Maria Raffa; Artur Słomka; Pietro Giorgio Malvidni; Roberto Lorusso; Michal Zembala; Piotr Suwalski; Mariusz Kowalewski
Journal:  Front Cardiovasc Med       Date:  2022-06-15

Review 4.  Staged hybrid totally thoracoscopic maze and catheter ablation for atrial fibrillation.

Authors:  Andrei Churyla; Rod Passman; Patrick M McCarthy; Olga N Kislitsina; Jane Kruse; James L Cox
Journal:  J Cardiovasc Electrophysiol       Date:  2022-06-24       Impact factor: 2.942

5.  Mid-term outcomes of concomitant Cox-Maze IV: Results from a multicenter prospective registry.

Authors:  Marc Gerdisch; Eric Lehr; Gansevoort Dunnington; John Johnkoski; Andrew Barksdale; Manesh Parikshak; Patrick Ryan; Samuel Youssef; Robert Fletcher; Glenn Barnhart
Journal:  J Card Surg       Date:  2022-07-23       Impact factor: 1.778

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.